RxDoctor Payments Data

William Culbertson, MD

Ophthalmology · Miami, FLNPI 1437126778

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,865 of the $11,230 with a category attached, or 70.0%. Johnson & Johnson Surgical Vision, Inc. accounts for 77.7% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $8,204 and has fallen 86.4% since, to $1,116 in 2025.

$11,230in general payments, 2019–2025

Across 52 payments — averaging $215.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Surgical Vision, Inc.$9K
  • Bausch & Lomb Americas Inc.$570
  • Alcon$455
  • Glaukos Corporation$368
  • Carl Zeiss Meditec USA, Inc.$282
  • Carl Zeiss Meditec, Inc.$214
  • plus $615 from 10 others

What the payments were for

  • Consulting fees$7,86570%
  • Food & beverage$3,32930%
  • Gifts$360%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,230 in reported general payments places this provider in the 85th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida →

Medicare billing

Part B allowed, 2024
$104,262
Medicare patients
399
Services billed
658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate148$9,089
Ketorolac Tromethamine97$3,355
Fluorometholone18$1,710
Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim84$701
Latanoprost35$345
Timolol Maleate28$261
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat19$213
Acyclovir12$56

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →